← Back to Search

Behavioural Intervention

Resistance Training for Muscle Growth (SLML Trial)

N/A

Waitlist Available

Led By Dr. Cameron Mitchell

Research Sponsored by University of British Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

19-30 years of age

Be between 18 and 65 years old

Must not have

Type one or type two diabetes

Drug therapy with any drugs that alter skeletal muscle metabolism (i.e., Metformin, Benzodiazepines)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from week 2 to week 4 and week 11 only.

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to study the effects of applying different levels of force to muscles during resistance training in young and healthy adults. Participants will undergo two types of resistance training conditions on their arms and legs - one

Who is the study for?

This trial is for young, healthy adults interested in muscle growth. Participants will engage in resistance training and undergo strength testing. They must be available to train twice a week for 12 weeks and visit the UBC MRI Research Facility at the beginning and end of the study.

What is being tested?

The trial tests two resistance training conditions: LONG (peak force at long muscle length) and SHORT (peak force at short muscle length). It aims to determine which condition leads to greater muscle hypertrophy and strength gains using Prime Fitness machines set differently.

What are the potential side effects?

Potential side effects may include typical exercise-related discomforts such as muscle soreness or fatigue due to resistance training. There might also be risks associated with MRI scans, like discomfort from lying still during the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 19 and 30 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have diabetes.

Select...

I am not taking drugs like Metformin or Benzodiazepines.

Select...

I do not have any major uncontrolled health issues.

Select...

I was diagnosed with cancer or treated for it within the last year.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from week 2 to week 4 and week 11 only.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from week 2 to week 4 and week 11 only.

This trial's timeline: 3 weeks for screening, Varies for treatment, and from week 2 to week 4 and week 11 only. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Muscle Volume

Secondary study objectives

Isokinetic Strength Testing

Isotonic Strength testing

Muscle Oxygenation

Other study objectives

Visual Analog Scale of Perceived Rating of Muscular Discomfort

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: SHORT and LONG Training ProtocolExperimental Treatment4 Interventions

Using a within subject design, participants will have the arms and legs from both left and right side of the body (divided by sagittal plane) randomly assigned to either LONG or SHORT conditions. Participants will then engage in maximal strength testing on Prime Fitness machines (1RM) as well as isokinetic strength testing (Biodex) in weeks 1 and 12. Participants will engage in the LONG and SHORT training sessions for 10 weeks in duration from week 2 until week 11.

0 / 5Eligibility criteria met